# FDA 483 - Ionetix Corporation - July 12, 2019

Source: https://www.keypedia.com/records/483/ionetix-corporation/2d06477e-fa6f-46a4-81b9-10fe4479c948

> FDA 483 for Ionetix Corporation on July 12, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Ionetix Corporation
- Inspection Date: 2019-07-12
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West II
- Summary: Ionetix Corporation, a PET drug manufacturer in Kansas City, KS, was cited for three observations during an FDA inspection. The firm lacked adequate production and process controls, specifically regarding media fill simulations for aseptic processing. Additionally, the inspection found failures to follow written quality assurance procedures and deficiencies in laboratory analytical methods, including employee training for visual inspections.

## Related Documents

- [483 - 2025-10-31](https://www.keypedia.com/records/483/ionetix-corporation/a6d87a79-ea3c-44a0-a6c9-1783a09f1361)

## Related Officers

- [Pharmaceutical Program Expert](https://www.keypedia.com/people/zachary-l-stamm/b729fab9-4d31-4c70-b5b3-e8b6207769c6)

Company: https://www.keypedia.com/companies/ionetix-corporation/a014fcbf-0e12-434a-bb00-adb100627897

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-ii/8851d151-0390-4d17-be66-fd86d12aa6b8